OC02_08 Validation of the World Heart Federation Evidence-Based Echocardiographic Criteria for Rheumatic Heart Disease
Different echocardiographic definitions of Rheumatic Heart Disease (RHD) have been used for screening for RHD. This led to development of the 2012 evidence-based World Heart Federation (WHF) echocardiographic criteria for RHD.1 (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: B. Remenyi, J. Carapetis, K. Sidhu, N. Wilson, International standardisation of echocardiographic diagnosis of rheumatic heart disease working group Tags: Oral Abstract Source Type: research

OC02_09 Next Generation Data Collection and Organizing System to Support Population-Based Screening for Rheumatic Heart Disease
With advances in portable ultrasonography and the development of World Heart Federation guidelines for echocardiographic diagnosis of RHD, population-based screening for RHD is increasingly common in Africa and other endemic regions. Screening generates large and complex datasets, which makes paper-based and non-networked data systems impractical. To our knowledge, an electronic solution designed for use in the field did not exist. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: J. van Dam, J.C. Lungu, E. Machila, S. Schwaninger, M. Phiri, P. Musonda, M. Gutierrez, J.M. Spector, B. Tadmor, J. Musuku Tags: Oral Abstract Source Type: research

OC02_10 Adherence to Secondary Prophylaxis for Rheumatic Heart Disease Patients Diagnosed Through Screening Is Inadequate for Disease Control
Echocardiographic screening for rheumatic heart disease (RHD) can detect candidates for secondary antibiotic prophylaxis (SAP), but will not improve disease control unless adherence to SAP is adequate. This is the first study to evaluate adherence to SAP specifically for RHD patients diagnosed through screening. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: D. Engelman, J. Kado, R. Mataika, M. Ahkee, S. Donath, T. Parks, J. Carapetis, A. Steer Tags: Oral Abstract Source Type: research

OC03_03 Prevalence, Characteristics and Outcomes of Atrial Fibrillation in the Sub Saharan Acute Heart Failure (Thesus -HF) Registry
AF is the most common arrhythmia in clinical practice and leads to a lower quality of life, increased risk of hospitalization, stroke and death. HF predicts the development of AF and conversely the presence of AF predicts the development of HF and their coexistence identifies individuals at higher mortality risk. In addition the profile of acute heart failure patients in sub Saharan Africa differs from that in the Western world (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: M.U. Sani, O.S. Ogah, B.A. Davison, G. otter, A. Damasceno, B.M. Mayosi, D.B. Ojji, A. Dzudie, C.K. Mondo, A. Suliman, C. Kouam Kouam, G. Yonga, S.A. Ba, F. Maru, K. Sliwa-Hahnle Tags: Oral Abstract Source Type: research

OC03_04 Relationship Between Six Minute Walk Test and Health-Related Quality of Life of Heart Failure Patients
The heart failure functional limitations affect some life aspects of patients: capabilities, symptoms and psychosocial characteristics; including emotional state, social interaction, intellectual functions, economic balance and health-related quality of life. The functional capacity of patients directly affects their quality of life and prognosis. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: V. Pel áez-Hernández, R. Pablo-Santiago, A. Orea-Tejeda, E. Pérez-Cabañas, J. Pineda-Juárez, C. Cintora-Martínez, D. González-Islas, R. Sánchez-Santillán, B. Santellano-Suárez, R. Herrera-Saucedo, E.W. Contreras-Ramírez Tags: Oral Abstract Source Type: research

OC04_03 Left Atrial Deformation Is Associated With Heart Failure in Hypertensive Patients
Heart failure with preserved ejection fraction (HFpEF) often develops in patients with left ventricular hypertrophy (LVH). (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: A. Stevanovic, M. Dekleva, R. Cvjetan Tags: Oral Abstract Source Type: research

OC04_04 Extreme Cardiac and Renal Mortality From Diabetes: 12-Year Blood-Based Prospective Study of 150,000 Mexican Adults
Previous studies of high-income (mostly Caucasian) populations have found that diabetes mellitus confers about a 3-fold increased risk of vascular disease at ages 40-59 and 2-fold increase at ages 60-69. In Mexico, diabetes is much more common than in most other countries but its relevance to mortality is unclear. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: J. Alegre-D íaz, W. Herrington, M. López-Cervantes, L. Gnatiuc, R. Ramirez, M. Hill, C. Baigent, S. Lewington, R. Collins, R. Tapia-Conyer, R. Peto, J. Emberson, P. Kuri-Morales, Mexico City Prospective Study Collaboration Tags: Oral Abstract Source Type: research

OC05_01 Task-Shifting for the Management of Hypertension: Lessons From the Global Alliance for Chronic Diseases
Task-shifting to non-physician health workers (NPHWs) has been an effective model for managing infectious diseases and improving maternal and child health. There is inadequate evidence to show the effectiveness of NPHWs to manage cardiovascular diseases (CVD). (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: R. Joshi, A. Thrift, D. Praveen, M. Ntim, E. Ng, R. Vedanthan, M. Thorogood, J. Gyamfi, The Global Alliance for Chronic Disease Task-shifting Working Group Tags: Oral Abstract Source Type: research

OC05_02 Cost of Hospitalization for Cardiovascular Diseases in India: Are We Pro-Poor?
Non Communicable Diseases (NCDs) account for 63% of the annual global deaths. Cardiovascular diseases (CVDs) are the largest cause of mortality and accounted for more than one-fourth of all deaths in India in 2008. Households spend a substantial share of their income on health care leading to catastrophic expenditure and impoverishment. However there is little information on the impact of healthcare expenditure on households due to CVDs. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: J.P. Tripathy, B. Prasad, H.D. Shewade, A.M. Kumar, A.D. Harries Tags: Oral Abstract Source Type: research

OC05_03 Variations in Cardiovascular Disease Risk Factors and Outcomes in South Asia
South Asia has among the highest burden of cardiovascular disease (CVD) in the world. However, there is little data examining how the incidence of CVD differs within the region, and whether these variations are predominantly attributable to CVD risk factor burden or other factors. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: P. Joseph, V.R. Kutty, V. Mohan, R. Kumar, P. Mony, R. Gupta, K. Vijayakumar, S. Islam, S. Rangarajan, S. Yusuf Tags: Oral Abstract Source Type: research

OC05_04 Ischemic Heart Disease Mortality and Morbidity In Former Soviet Union Countries, 1990-2013: The Global Burden of Disease Study 2013
Since the dissolution of the former Soviet Union (fSU) in 1991, some former member countries and satellite states have fared better than others in terms of ischemic heart disease (IHD). The Global Burden of Disease 2013 Study compared standardized data on IHD mortality and disability adjusted-life years (DALYs) and ranking of IHD risk factors across fSU countries and their regions (Central Asia, Central Europe and Eastern Europe) in 1990 and 2013. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: A. Murphy, G.A. Roth, F. Mohammad, M. Naghavi, M. Ng, N. Pogosova, T. Vos, C.J. Murray, A. Moran Tags: Oral Abstract Source Type: research

OC06_01 Association of Nutrients With Blood Lipids in 19 Countries and 5 Continents: The Pure Study
For decades, blood total cholesterol (TC) was assumed to be a robust surrogate marker to predict CVD. A reduction in saturated fats with a concomitant increase in carbohydrates has been proposed to reduce TC level and presumably CVD, but this has recently been challenged and there are no data from low and middle income countries where > 80% of CVD occurs. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: M. Dehghan, S. Anand, A. Mente, S. Yusuf, PURE study working group Tags: Oral Abstract Source Type: research

OC06_02 Risk Awareness in a New Community Program for Cardiovascular Health in Milan, Italy
For people to follow a heart-friendly lifestyle and other cardiovascular (CV) preventive actions, awareness of own risk may be a prerequisite. Risk awareness requires health literacy and self-knowledge. Both depend on many conditions (e.g. access to screening, educational level, input from advocacy actions, language barriers, etc), which are context-specific. ProSalute is an experimental free-access program of Primary CV prevention for the prevalently medium/low-income and multiethnic community of the neighborhood of Ponte Lambro, Milan, Italy (n=3600 adults). (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: J.P. Werba, M. Giroli, N. Simonelli, L. Vigo, M. Amato, A. Gorini, A. Bonomi, F. Veglia, E. Tremoli Tags: Oral Abstract Source Type: research

OC06_03 An International Pilot Study of the Barriers and Facilitators to the Use of Evidence Based Drugs in the Secondary Prevention of Cardiovascular Diseases
Rates of evidence-based cardiovascular medication (EBM) use globally are sub-optimal, and are poorest in low-income countries. An understanding of the barriers and facilitators of EBM use among countries of different incomes may allow innovative approaches to be developed to optimize cardiovascular disease (CVD) prevention. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: S. Khandelwal, V. Peck, L. Nambiar, M. Saxena, D. Leong, A. Banerjee, J.P. Werba, J.R.F. Neto, M. Moniruzzaman, K.C. Quinto, CARDIOMAPPS group Tags: Oral Abstract Source Type: research

OC06_04 Effectiveness and Safety of Exercise Training in Children With Congenital Heart Disease
Congenital heart disease (CHD) is the most prevalent malformation in childhood, and improvement in surgical techniques increased survival among them. They usually reach adulthood. Nowadays, these children need to return to school, and return to their lives. Worldwide, few health services offer cardiac rehabilitation programs (CRP) for these patients. Therefore knowledge about effectiveness and safety of this kind of therapy remain uncertain. (Source: CVD Prevention and Control)
Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: M.-D. Rius-Su árez, H. Ilarraza-Lomelí, J. Rojano, M.E. Franco, M. García, I. Miranda, A. Buendía, A. Benita, E. Patiño, S. Ramírez Tags: Oral Abstract Source Type: research